MTs overexpression was frequently reported to be associated with poor prognosis in a wide range of human cancers, such as hepatocellular carcinoma, breast cancer, glioblastoma, oral cancer, and melanoma [23, 35–38]. The gene discussed is TIMM8A; the disease is melanoma.